Related Experiment Video
Updated: May 27, 2026
09:46
Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus
Published on: March 8, 2015
[Role of deep brain stimulation in epilepsy]
József Janszky1, István Balás, Norbert Kovács
1Pécsi Tudományegyetem, Neurológiai Klinika, Pécs. janszky@index.hu
Ideggyogyaszati Szemle
|November 9, 2011
Summary
Deep brain stimulation (DBS) of the anterior nucleus of the thalamus (ANT) is an established epilepsy treatment. ANT-DBS offers significant improvement for drug-resistant epilepsy when other options fail.
Area of Science:
- Neuroscience
- Neurosurgery
- Epileptology
Context:
- Deep brain stimulation (DBS) is an evolving therapeutic modality for neurological disorders.
- Randomized trials have validated DBS efficacy, leading to its approval for various brain conditions.
- Epilepsy treatment is exploring novel targets for DBS interventions.
Purpose:
- To evaluate the efficacy of anterior nucleus of the thalamus (ANT) deep brain stimulation (DBS) for drug-resistant epilepsy.
- To compare ANT-DBS outcomes with antiepileptic drugs and epilepsy surgery.
- To identify patient populations who may benefit from ANT-DBS as a last resort.
Summary:
- Anterior nucleus of the thalamus (ANT) deep brain stimulation (DBS) is a proven method for epilepsy treatment.
- Ongoing trials investigate other potential DBS targets like the subthalamic nuclei and amygdala-hippocampus complex.
- ANT-DBS yields significant improvements in about 50% of drug-resistant epilepsy patients, with 10% achieving seizure freedom.
- ANT-DBS is considered an 'ultima ratio' for adult drug-resistant epilepsy patients unsuitable for medication or surgery.
Impact:
- ANT-DBS provides a valuable therapeutic option for refractory epilepsy cases.
- This research informs clinical decision-making for complex epilepsy management.
- The findings highlight the potential of neuromodulation in treating intractable neurological conditions.
